{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:12:56Z","timestamp":1777486376592,"version":"3.51.4"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the efficacy of combined prediction of serum ferritin, Hcy, CRP, and fat ultrasound parameters in metabolic dysfunction-associated steatotic liver disease (MASLD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>One hundred and two MASLD patients admitted to our hospital from November, 2021 to November, 2023 were selected as the MASLD group, and 106 healthy subjects were selected as healthy group on the basis of the principle of 1:1, and the healthy group was not accompanied by any basic diseases. The differences in demographic data, medical records and biochemical indicators between the MASLD group and the healthy group were analyzed by single factor analysis. The suspected influencing factors of MASLD were screened by single factor analysis. Apply multivariate Logistic regression to examine the independent predictors of MASLD. Employ ROC curve to anticipate the effect of single and combined indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Single factor analysis revealed that the SF, Hcy, CRP, and CAP level in MASLD group were significantly higher than healthy control group (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05). Multivariate Logistic analysis displayed that SF, Hcy, CRP, and CAP were independent predictors of alcoholic fatty liver disease (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05). ROC curve displayed that the area under the curve of the joint prediction of SF, Hcy, CRP, and CAP was 0.941, which was significantly higher than the area of SF, Hcy, CRP, and CAP alone.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The combined application of serum SF, Hcy, CRP, and CAP has a high predictive efficiency for MASLD, which can be employed as an important reference indicator for early clinical diagnosis and intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1637694","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:43:01Z","timestamp":1765953781000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy analysis of serum ferritin, Hcy, CRP combined with fat ultrasound parameters in predicting metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Haitao","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liju","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linjian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"15489","DOI":"10.3390\/ijms232415489","article-title":"Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment","volume":"23","author":"Guo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jhep.2017.11.028","article-title":"Role of imaging-based biomarkers in NAFLD: recent advances in clinical application and future research directions","volume":"68","author":"Loomba","year":"2018","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.2174\/1381612825666190117102111","article-title":"Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts","volume":"24","author":"Papatheodoridi","year":"2018","journal-title":"Curr Pharm Des"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/gutjnl-2023-330815","article-title":"Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease","volume":"73","author":"Armandi","year":"2024","journal-title":"Gut"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/ajcn\/nqac285","article-title":"Homocysteine, folate, and nonalcoholic fatty liver disease: a systematic review with meta-analysis and Mendelian randomization investigation","volume":"116","author":"Yuan","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.3390\/biomedicines11102711","article-title":"The potential role of C-reactive protein in metabolic-dysfunction-associated fatty liver disease and aging","volume":"11","author":"Ding","year":"2023","journal-title":"Biomedicine"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1159\/000360510","article-title":"Non-alcoholic fatty liver disease: diagnosis and investigation","volume":"32","author":"Nascimbeni","year":"2014","journal-title":"Dig Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"880298","DOI":"10.3389\/fimmu.2022.880298","article-title":"Association of Inflammatory Cytokines with non-Alcoholic Fatty Liver Disease","volume":"13","author":"Duan","year":"2022","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e0251","DOI":"10.1097\/HC9.0000000000000251","article-title":"The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019","volume":"7","author":"Paik","year":"2023","journal-title":"Hepatol Commun"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.3748\/wjg.v29.i17.2534","article-title":"Non-invasive evaluation of liver steatosis with imaging modalities: new techniques and applications","volume":"29","author":"Zeng","year":"2023","journal-title":"World J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.acra.2023.07.001","article-title":"Diagnostic performance of quantitative ultrasound parameters in non-alcoholic fatty liver disease","volume":"31","author":"Torkzaban","year":"2023","journal-title":"Acad Radiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12876-024-03160-8","article-title":"Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1007\/s00261-020-02573-9","article-title":"Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid","volume":"45","author":"Barr","year":"2020","journal-title":"Abdom Radiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep.24706","article-title":"Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"55","author":"Kowdley","year":"2012","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/jgh.13235","article-title":"The development of a non-invasive model to predict the presence of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease","volume":"31","author":"Goh","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e13895","DOI":"10.1111\/eci.13895","article-title":"Association between homocysteine and nonalcoholic fatty liver disease: Mendelian randomisation study","volume":"53","author":"Fu","year":"2023","journal-title":"Eur J Clin Investig"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"21202","DOI":"10.3390\/ijms151121202","article-title":"Plasma levels of homocysteine and cysteine increased in pediatric NAFLD and strongly correlated with severity of liver damage","volume":"15","author":"Pastore","year":"2014","journal-title":"Int J Mol Sci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"848937","DOI":"10.3389\/fendo.2022.848937","article-title":"High-sensitive CRP correlates with the severity of liver steatosis and fibrosis in obese patients with metabolic dysfunction associated fatty liver disease","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Endocrinol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jdmv.2021.03.008","article-title":"Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: a case-control study in Algerian population","volume":"46","author":"Taharboucht","year":"2021","journal-title":"J Med Vasc"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.jacc.2005.06.017","article-title":"Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation","volume":"46","author":"Calabro","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.clnesp.2024.01.017","article-title":"The association between dietary inflammatory index (DII) scores and c-reactive protein (CRP) and nonalcoholic fatty liver disease (NAFLD) in a general population cohort","volume":"60","author":"Doustmohammadian","year":"2024","journal-title":"Clin Nutr ESPEN"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1637694\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:43:05Z","timestamp":1765953785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1637694\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":26,"alternative-id":["10.3389\/fmed.2025.1637694"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1637694","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"article-number":"1637694"}}